Sheana Nieh

Mercaptor Discoveries, Inc. is a pharmaceutical company based in Novato, CA. The private company develops chemistry that gives CNS drugs potency without the commonly found toxicity. The company's approach flows from their discovery of chemistry existing within areas of the brain suffering neuropathology. Applying their discovery to neurology has illuminated a path forward for neurotherapeutics, delivering drugs capable of mounting a dynamic response to brain damage and dysfunction. Mercaptor Discoveries is a platform company with preclinical programs in neurology. The company's founding scientists discovered injury-activated molecules, called captons™ while at Raptor Pharmaceuticals, which they co-founded in 2006 and grew into a commercial company. Captons have reproducible proof-of-concept and efficacy as neuroprotectants and have the potential to prevent the progression of traumatic brain injury (TBI) and neurodegenerative diseases such as Alzheimer's disease, ALS, epilepsy, Parkinson's disease, MS, and stroke. The company was founded in 2016 by Todd Zankel, Sara Isbell, and Kim R. Tsuchimoto. Sara Isbell has been the CEO since 2016.